Rick E. Winningham
Chief Executive Officer at Theravance Biopharma · 21 reported transactions in 2 companies · latest trade May 22, 2026
Their trades
Sold | May 22, 2026 | May 22, 2026 close $239.83 → Oct 28, 2026 close $205.06. S&P 500 +3.2% over the same days. |
$662.1K
May 22, 2026 close $239.83 → Oct 28, 2026 close $205.06. S&P 500 +3.2% over the same days.